Selective drug delivery to bone using acidic oligopeptides

Journal of Bone and Mineral Metabolism

Volumn 27, Issue 1, 2009, Pages 1-8

  Ishizaki, Junko ^a   Waki, Yoshihiro ^b   Takahashi Nishioka, Tatsuo ^c   Yokogawa, Koichi ^a   Miyamoto, Ken Ichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

^c HOKURIKU UNIVERSITY   (Japan)

Author keywords

Acidic oligopeptide; Drug delivery; Estradiol; Levofloxacin; Tissue nonspecific alkaline phosphatase

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; LEVOFLOXACIN; NORFLOXACIN; OLIGOPEPTIDE; OSTEOPONTIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; BONE DENSITY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; HYDROLYSIS; NONHUMAN; OSTEOMYELITIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

ALKALINE PHOSPHATASE; AMINO ACID SEQUENCE; BONE AND BONES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ESTRADIOL; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; OLIGOPEPTIDES; OSTEOMYELITIS; OSTEOPONTIN; OSTEOPOROSIS; QUINOLONES; SIALOGLYCOPROTEINS;

EID: 58149196258     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-008-0004-z     Document Type: Review

References (54)

1. CL De Ligny WJ Gelseman TG Tji YM Huigen HA Vink 1990 Bone-seeking radiopharmaceuticals Nucl Med Biol 17 161 179
2. A Ezra G Golomb 2000 Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption Adv Drug Delivery Rev 42 175 195
3. J Fujisaki Y Tokunaga T Takahashi T Hirose F Shimojo A Kagayama T Hata 1995 Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. I: Synthesis and in vivo characterization of osteotropic carboxyfluorescein J Drug Target 3 273 282
4. J Fujisaki Y Tokunaga T Takahashi F Shimojo S Kimura T Hata 1998 Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug: i.v. effects of osteotropic estradiol on bone mineral density and uterine weight in ovariectomized rats J Drug Target 5 129 138
5. H Uludag T Gao GR Wohl D Kantoci RF Zernicke 2000 Bone affinity of a bisphosphonate-conjugated protein in vivo Biotechnol Prog 16 1115 1118
6. SA Gittens G Bansal RF Zernicke H Uludag 2005 Designing proteins for bone targeting Adv Drug Delivery Rev 57 1011 1036
7. A Oldberg A Franzén D Heinegård 1986 Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence Proc Natl Acad Sci USA 83 8819 8823
8. T Nagata CG Bellows S Kasugai WT Butler J Sodek 1991 Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture Biochem J 274 513 520
9. S Kasugai T Nagata J Sodek 1992 Temporal studies on the tissue compartmentalization of bone sialoprotein (BSP), osteopontin (OPN), and SPARC protein during bone formation in vitro J Cell Physiol 152 467 477
10. T Sekido N Sakura Y Higashi K Miya Y Nitta M Nomura H Sawanishi K Morito Y Masamune S Kasugai K Yokogawa K Miyamoto 2001 Novel drug delivery system to bone using acidic oligopeptide; pharmacokinetic characteristics and pharmacological potential J Drug Target 9 111 121
11. S Kasugai R Fujisawa Y Waki K Miyamoto K Ohya 2000 Selective drug delivery system to bone; small peptide (Asp)6 conjugation J Bone Miner Res 15 936 943
12. BS Komm CM Terpening DJ Benz KA Graeme A Gallegos M Korc GL Greene BW O'Malley MR Haussler 1988 Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells Science 241 81 84
13. EF Eriksen DS Colvard NJ Berg ML Graham KG Mann TC Spelsberg BL Riggs 1988 Evidence of estrogen receptors in normal human osteoblast-like cells Science 241 84 86
14. MJ Oursler P Osdoby J Pyfferoen BL Riggs TC Spelsberg 1991 Avian osteoclasts as estrogen target cells Proc Natl Acad Sci USA 88 6613 6617
15. Y Onoe C Miyaura H Ohta S Nozawa T Suda 1997 Expression of estrogen receptor beta in rat bone Endocrinology 138 4509 4512
16. J Arts GG Kuiper JM Janssen JA Gustafsson CW Löwik HA Pols JP van Leeuwen 1997 Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells Endocrinology 138 5067 5070
17. SD Bain MC Bailey MW Edwards 1992 The anabolic effect of estrogen on endosteal bone formation in the mouse is attenuated by ovariohysterectomy: a role for the uterus in the skeletal response to estrogen? Calcif Tissue Int 51 223 228
18. TJ Wronski CF Yen H Qi LM Dann 1993 Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats Endocrinology 132 823 831
19. R Lindsay JF Tohme 1990 Estrogen treatment of patients with established postmenopausal osteoporosis Obstet Gynecol 76 290 295
20. B Astedt 1981 On the role of estrogens in endometrial carcinogenesis Acta Obstet Gynecol Scand 106 suppl 33 35
21. RD Gambrell 1982 The menopause; benefits and risks of estrogen-progestogen replacement therapy Fertil Steril 37 457 474
22. K Yokogawa K Miya T Sekido Y Higashi M Nomura R Fujisawa K Morito Y Masamune Y Waki S Kasugai K Miyamoto 2001 Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice Endocrinology 142 1228 1233
23. JM Larner NJ MacLusky RB Hochberg 1985 The naturally occurring C-17 fatty acid esters of estradiol are long-acting estrogens J Steroid Biochem 22 407 413
24. JM Larner RB Hochberg 1985 The clearance and metabolism of estradiol and estradiol-17-esters in the rat Endocrinology 117 1209 1214
25. RJ Hershcopf HL Bradlow J Fishman GE Swaneck JM Larner RB Hochberg 1985 Metabolism of estradiol fatty acid esters in man J Clin Endocrinol Metab 61 1071 1075
26. K Yokogawa K Toshima K Yamoto T Nishioka N Sakura K Miyamoto 2006 Pharmacokinetic advantage of an intranasal preparation of a novel anti-osteoporosis drug, l-Asp-hexapeptide-conjugated estradiol Biol Pharm Bull 29 1229 1233
27. DR Dirschl LC Almekinders 1993 Osteomyelitis. Common causes and treatment recommendations Drugs 45 29 43
28. JT Mader M Ortiz JH Calhoun 1996 Update on the diagnosis and management of osteomyelitis Clin Podiatr Med Surg 13 701 724
29. JT Mader D Mohan J Calhoun 1997 A practical guide to the diagnosis and management of bone and joint infections Drugs 54 253 264
30. MP Weinstein CW Stratton HB Hawley A Ackley LB Reller 1987 Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis Am J Med 83 218 222
31. JT Mader JS Cantrell J Calhoun 1990 Oral ciprofloxacin compared with standard parenteral antibiotic therapy for chronic osteomyelitis in adults J Bone Joint Surg [Am] 72 104 110
32. Takahashi TN, Kobayashi S, Miyamoto K (2008) Bone targeting of quinolone antibiotics conjugated with an acidic oligopeptide. Pharm Res (Epub ahead of print). doi: 10.1007/s11095-008-9605-4
33. RJ Lewis FT Tsai DB Wigley 1996 Molecular mechanisms of drug inhibition of DNA gyrase Bioessays 18 661 667
34. LL Shen DTW Chu 1996 Type II DNA topoisomerases as antibacterial targets Curr Pharm Des 2 195 208
35. JM Blondeau 1999 Expanded activity and utility of the new fluoroquinolones; a review Clin Ther 21 3 40
36. JA O'Donnell SP Gelone 2000 Fluoroquinolones Infect Dis Clin N Am 14 489 513
37. J Blaser BB Stone MC Groner SH Zinner 1987 Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance Antimicrob Agents Chemother 31 1054 1060
38. SL Preston GL Drusano AL Berman CL Fowler AT Chow B Dornseif V Reichl J Natarajan M Corrado 1998 Pharmacodynamics of levofloxacin; a new paradigm for early clinical trials JAMA 279 125 129
39. Whyte MP (2001) Hypophosphatasia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill, New York, pp 5313-5329
40. DW Moss RH Eaton JK Smith LG Whitby 1967 Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparations Biochem J 102 53 57
41. FA Leone LA Rezende P Ciancaglini JM Pizauro 1998 Allosteric modulation of pyrophosphatase activity of rat osseous plate alkaline phosphatase by magnesium ions Int J Biochem Cell Biol 30 89 97
42. HC Anderson 1988 Mechanisms of pathologic calcification Rheum Dis Clin N Am 14 303 319
43. H Fleisch RG Russell F Straumann 1966 Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis Nature (Lond) 212 901 903
44. AS de Jong TJ Hak P van Duijn 1980 The dynamics of calcium phosphate precipitation studied with a new polyacrylamide steady state matrix-model; influence of pyrophosphate collagen and chondroitin sulfate Connect Tissue Res 7 73 79
45. JL Meyer 1984 Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys 231 1 8
46. MP Whyte R Valdes LM Ryan WH McAlister 1982 Infantile hypophosphatasia; enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease J Pediatr 101 379 386
47. MP Whyte WH McAlister LS Patton HL Magill MD Fallon WB Lorentz HG Herrod 1984 Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma; results in three additional patients J Pediatr 105 926 933
48. MP Whyte HL Magill MD Fallon HG Herrod 1986 Infantile hypophosphatasia; normalization of circulating bone alkaline phosphatase activity followed by skeletal remineralization. Evidence for an intact structural gene for tissue nonspecific alkaline phosphatase J Pediatr 108 82 88
49. M Weninger RA Stinson H Plenk P Böck A Pollak 1989 Biochemical and morphological effects of human hepatic alkaline phosphatase in a neonate with hypophosphatasia Acta Paediatr Scand 360 154 160
50. MP Whyte M Landt LM Ryan RA Mulivor PS Henthorn KN Fedde JD Mahuren SP Coburn 1995 Alkaline phosphatase; placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5′-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy J Clin Invest 95 1440 1445
51. M Murshed D Harmey JL Millán MD McKee G Karsenty 2005 Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone Genes Dev 19 1093 1104
52. T Nishioka S Tomatsu MA Gutierrez K Miyamoto GG Trandafirescu PL Lopez JH Grubb R Kanai H Kobayashi S Yamaguchi GS Gottesman R Cahill A Noguchi WS Sly 2006 Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide Mol Genet Metab 88 244 255
53. RJ Walton CJ Preston RG Russell JA Kanis 1975 An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease Clin Chim Acta 63 227 229
54. T Komoda Y Sakagishi 1987 The function of carbohydrate moiety and alteration of carbohydrate composition in human alkaline phosphatase isoenzymes Biochim Biophys Acta 523 395 406